These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7754830)

  • 1. Contemporaneous bilateral postero-ventral pallidotomy for early onset "juvenile type" Parkinson's disease. Case report.
    Iacono RP; Lonser RR; Yamada S
    Acta Neurochir (Wien); 1994; 131(3-4):247-52. PubMed ID: 7754830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P; Lenz FA; Chase TN
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract]   [Full Text] [Related]  

  • 3. Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial.
    de Bie RM; de Haan RJ; Nijssen PC; Rutgers AW; Beute GN; Bosch DA; Haaxma R; Schmand B; Schuurman PR; Staal MJ; Speelman JD
    Lancet; 1999 Nov; 354(9191):1665-9. PubMed ID: 10568567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease.
    Skalabrin EJ; Laws ER; Bennett JP
    Mov Disord; 1998 Sep; 13(5):775-81. PubMed ID: 9756145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
    Block G; Liss C; Reines S; Irr J; Nibbelink D
    Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pallidotomy on Parkinson's disease: study design and assessment techniques.
    Gross RE; Lozano AM; Lang AE; Tasker RR; Hutchison WD; Dostrovsky JO
    Acta Neurochir Suppl; 1997; 68():24-8. PubMed ID: 9233409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease.
    Uitti RJ; Wharen RE; Turk MF
    Neurology; 1998 Dec; 51(6):1755-7. PubMed ID: 9855542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR; Sage JI; Lang AE; Mark MH
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease.
    Sutton JP; Couldwell W; Lew MF; Mallory L; Grafton S; DeGiorgio C; Welsh M; Apuzzo ML; Ahmadi J; Waters CH
    Neurosurgery; 1995 Jun; 36(6):1112-6; discussion 1116-7. PubMed ID: 7643989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease.
    Brodsky MA; Hogarth P; Nutt JG
    Mov Disord; 2006 Sep; 21(9):1487-90. PubMed ID: 16721730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection criteria for unilateral posteroventral pallidotomy.
    Alterman RL; Kelly P; Sterio D; Fazzini E; Eidelberg D; Perrine K; Beric A
    Acta Neurochir Suppl; 1997; 68():18-23. PubMed ID: 9233408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
    Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR
    Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medial posteroventral pallidotomy for the treatment of Parkinson's disease].
    Krauss JK; Grossman RG; Lai EC; Schwartz K; Jankovic J
    Zentralbl Neurochir; 1997; 58(4):153-62. PubMed ID: 9487651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):112. PubMed ID: 26218794
    [No Abstract]   [Full Text] [Related]  

  • 15. Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features.
    Catalán MJ; Escribano PM; Alonso-Frech F
    Mov Disord; 2017 Apr; 32(4):624-625. PubMed ID: 28116835
    [No Abstract]   [Full Text] [Related]  

  • 16. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Wolters EC; Horstink MW; Roos RA; Jansen EN
    Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
    Facca A; Sanchez-Ramos J
    Mov Disord; 1996 May; 11(3):327-9. PubMed ID: 8723153
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications.
    Samuel M; Caputo E; Brooks DJ; Schrag A; Scaravilli T; Branston NM; Rothwell JC; Marsden CD; Thomas DG; Lees AJ; Quinn NP
    Brain; 1998 Jan; 121 ( Pt 1)():59-75. PubMed ID: 9549488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience.
    Bohlega S; Abou Al-Shaar H; Alkhairallah T; Al-Ajlan F; Hasan N; Alkahtani K
    Eur Neurol; 2015; 74(5-6):227-36. PubMed ID: 26618531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical analysis of L-dopa induced dyskinesia treated by posteroventral pallidotomy for Parkinson's disease].
    Zhao G; Li Y; Shao M; Ding Y
    Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):482-4. PubMed ID: 11829894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.